✦ LIBER ✦

503 Phase I radioimmunotherapy (RIT) study of 90Y-CC49 monoclonal antibody (MAb) therapy in patients with advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Robert, F.; Meredith, R.F.; Khazaeli, M.B.; Russell, C.; Grizzle, W.; Newsome, J.; Saleh, M.; LoBuglio, A.F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I/II study of antibody targeted

✍ Lorigan, P; Carmichael, J; Woll, P.J; O'Byrne, K; Browne, S; Sopwith, M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

34 Phase II study of LY231514 in patient

✍ Clarke, S.; Boyer, M.; Millward, M.; Findlay, M.; Ackland, S.; Childs, A.; Brew, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 161 KB

A Phase I study of Nedaplatin (CDGP) and

✍ Saito, J; Nakai, Y; Koinumaru, S; Matsuda, T; Saijo, Y; Nukiwa, T 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Phase I study of paclitaxel, carboplatin

✍ Yasushi Ono; Mitsunori Hino; Yuka Ueda; Ryoko Kamizuru; Masatoshi Omata; Takashi 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 123 KB

A phase II study of low dose vinorelbine

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 134 KB

A phase I trial of gefitinib and nimotuz

✍ Kim, Se Hyun; Shim, Hyo Sup; Cho, Jaeho; Jeong, Jae Heon; Kim, Sun Mi; Hong, Yun 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 275 KB